Hypha Labs, Inc. Files 8-K for Bylaws and Financials

Ticker: FUNI · Form: 8-K · Filed: Jan 16, 2025 · CIK: 1502966

Sentiment: neutral

Topics: corporate-governance, financial-reporting, bylaws

TL;DR

Hypha Labs (formerly Digipath) filed an 8-K on Jan 15, 2025, for bylaw changes and financials.

AI Summary

Hypha Labs, Inc. (formerly Digipath, Inc.) filed an 8-K on January 16, 2025, reporting changes related to its Articles of Incorporation or Bylaws and financial statements. The company, incorporated in Nevada with its principal executive offices in Las Vegas, NV, operates in the testing laboratories sector.

Why It Matters

This filing indicates updates to Hypha Labs' corporate governance and financial reporting, which are crucial for investors to understand the company's operational and legal status.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant negative or positive news that would immediately impact the stock price.

Key Players & Entities

FAQ

What specific amendments were made to the Articles of Incorporation or Bylaws?

The filing indicates that Item 5.03 pertains to Amendments to Articles of Incorporation or Bylaws, but the specific details of these amendments are not provided in the excerpt.

What financial statements are being filed with this 8-K?

The filing indicates that Item 9.01 pertains to Financial Statements and Exhibits, but the specific financial statements are not detailed in the provided excerpt.

When was Hypha Labs, Inc. formerly known as Digipath, Inc.?

The company was formerly known as Digipath, Inc. with a date of name change listed as September 19, 2018.

What is the Standard Industrial Classification (SIC) code for Hypha Labs, Inc.?

The SIC code for Hypha Labs, Inc. is 8734, which corresponds to SERVICES-TESTING LABORATORIES.

What is the fiscal year end for Hypha Labs, Inc.?

The fiscal year end for Hypha Labs, Inc. is September 30.

Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-01-16 16:43:18

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Hypha Labs, Inc. Date: January 16, 2025 By: /s/ A. Stone Douglass A. Stone Douglass Chairman, President, Chief Executive Officer, Chief Financial Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing